Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Celecoxib copromotion agreement expanded

March 26, 1998

First report of nonpeptide compounds as MHC class II inhibitors

March 26, 1998

Further mechanism-of-action studies conducted on T-614

March 26, 1998

New mechanism identified for Fujisawa antiinflammatory agent

March 26, 1998

FDA okays protocol amendments for phase III trial of CBP-1011

March 26, 1998

UPMC leads the way in gene therapy for musculoskeletal disorders

March 25, 1998

P-gp as a complicating factor in childhood rheumatic diseases

March 24, 1998

Anergen files IND for AnergiX

March 24, 1998

Cyclic sulfones synthesized at Pfizer inhibit MMPs and TNF production

March 23, 1998

Antiinflammatory agents with a good safety profile disclosed by Taisho

March 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...